Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Johnson Insider Profile
4 Followers
John Johnson, CEO, Director at Melinta Therapeutics, holds 37.40K shares in Melinta Therapeutics (Ticker: MLNTQ), holds ― shares in AVEO Pharma (Ticker: AVEO), holds 522.15K shares in Strongbridge Biopharma (Ticker: SBBP). Most recently, John Johnson Sold ― shares of Melinta Therapeutics on Jul 02, 2019 for an estimated value of 72.41K.
John Johnson Melinta Therapeutics (MLNTQ)CEO, Director
Melinta Therapeutics (MLNTQ)
CEO, Director
Ranked #6,857 out of 78,624 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+118.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Johnson holds in companies
Most Profitable Insider Trade
Stock:
Melinta Therapeutics
(MLNTQ)
(MLNTQ)
Rating:Informative Buy
Date:May 28, 2014 - May 28, 2015
Return:+297.50%
The most profitable trade made by John Johnson
John Johnson's Trading History
Melinta Therapeutics
Jul 02, 2019
―
Informative Sell
72.41K
$4.11K
AVEO Pharma
―
Director
―
―
Strongbridge Biopharma
Jul 07, 2020
CEO, Director
Uninformative Buy
―
$1.44M
Verastem
―
Director
―
―
Sucampo Pharmaceuticals
Feb 13, 2018
―
Uninformative Sell
92.34K
$0.00
Portola Pharma
Jul 02, 2020
―
Uninformative Sell
237.49K
$0.00
Ocugen
―
Director
―
$0.00
Dendreon Corp
Jul 08, 2014
―
Uninformative Sell
27.69K
―
Eli Lilly & Co
―
Sr. VP, Oncology Business Unit
―
$0.00
Savient Pharmaceuticals
Feb 02, 2011
―
Uninformative Buy
―
―
Ocera Therapeutics
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see John Johnson's performance on stock
You May Also Like
John Johnson insider profile FAQ
What is the percentage of profitable transactions made by John Johnson?
The percentage of profitable transactions made by John Johnson is 67%.
What is the average return per transaction made by John Johnson?
The average return per transaction made by John Johnson is 118.80%.
What stocks does John Johnson hold?
John Johnson holds: MLNTQ, AVEO, SBBP, VSTM, SCMP, PTLA, OCGN, DNDNQ, LLY, SVNTQ, OCRX stocks.
What was John Johnson’s latest transaction?
John Johnson latest transaction was an Informative Sell of $72.41K.
What was John Johnson's most profitable transaction?
John Johnson’s most profitable transaction was an Informative Buy of MLNTQ stock on May 28, 2014. The return on the trade was 297.50%.
What is John Johnson's role in Melinta Therapeutics?
John Johnson's role in Melinta Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.